SU1202591A1 - Method of treatment of patients ill with allergic dermatosis - Google Patents
Method of treatment of patients ill with allergic dermatosis Download PDFInfo
- Publication number
- SU1202591A1 SU1202591A1 SU813278185A SU3278185A SU1202591A1 SU 1202591 A1 SU1202591 A1 SU 1202591A1 SU 813278185 A SU813278185 A SU 813278185A SU 3278185 A SU3278185 A SU 3278185A SU 1202591 A1 SU1202591 A1 SU 1202591A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- treatment
- days
- allergic dermatosis
- allergic
- dermatosis
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Изобретение относитс к медицине и может быть использовано дл лечени аллергических дерматозов.This invention relates to medicine and can be used to treat allergic dermatoses.
Целью изобретени вл етс сокращение сроков лечени .The aim of the invention is to reduce the duration of treatment.
Пример 1. Больна К. 42 лет х оспитализирована в т желом состо - нии. При обследовании установлен диагноз аллергического дерматоза лекарственной этиологии. Лечение начали с введени триоксазина в течение 3 дней на фоне приема кортикостеро- идов. После отмены триоксазина больной назначили кватерон, который больна принимала одновременно с кортикостероидами. Общий курс лечени , в том числе и кортикостероидами , длилс 17 дней. Клиническое выздоровление наступило к 16-му дню лечени .Example 1. Sick K., 42 years old, was capitalized in a difficult condition. During the examination, a diagnosis of allergic dermatosis of drug etiology was established. Treatment began with the administration of trioxazine for 3 days while taking corticosteroids. After discontinuation of trioxazin, the patient was prescribed quaterone, which the patient was taking along with corticosteroids. The general course of treatment, including corticosteroids, lasted 17 days. Clinical recovery occurred by the 16th day of treatment.
Пример 2. Больна Г. 43 лет При поступлении установлен диагноз - аллергический дерматоз лекарст-. венной этиологии. Больной назначен комплексно-последовательный курсExample 2. Ill, 43 years old. Upon admission, a diagnosis was made - allergic dermatosis drug. etiology. The patient is assigned a complex-sequential course.
Редактор В.ИвановаEditor V.Ivanova
Составитель Ю.Емцов Техред С.МигуноваCompiled by Y. Yemtsov Tehred S. Migunova
Заказ 8345/5 Тираж 721Order 8345/5 Circulation 721
ВНИИПИ Государственного комитета СССРVNIIPI USSR State Committee
по делам изобретений и открытий 113035, Москва, Ж-35, Раушска наб,, д. 4/5for inventions and discoveries 113035, Moscow, Zh-35, Raushsk nab, 4/5
Филиал ППП Патент, г. Ужгород, ул. Проектна , 4Branch PPP Patent, Uzhgorod, st. Project, 4
, ,
12025911202591
лечени в соответствии с предлагаемым способом - триоксазин в течение трех дней, кватерон в течение трех дней на фоне приема кортикостероидов 5 общей дозой 120 мг. Вьтисана в состо нии клинического извлечени через 16 дней.treatment in accordance with the proposed method - trioxazine for three days, quaterone for three days while taking corticosteroids 5 with a total dose of 120 mg. Vytisana in a state of clinical extraction after 16 days.
Пример 3. Больной М. 18 лет госпитализирован по поводу часто 10 рецидивирующего атопического дерматита , на фоне которого развилась лекарственна болезнь. Больному назначен комплексно-последовательный курс .лечени , в течение одноготрех дней триоксазин внутрь, аExample 3. Patient M., 18 years old, was hospitalized for often 10 recurrent atopic dermatitis, against the background of which drug disease developed. The patient was prescribed a complex-sequential course of treatment, for one or three days, trioxazine was inside, and
последующие три дн - кватерон, затем еще п ть дней аминокапроновую кислоту одновременно с триамсиноло- ном по 4 мг два раза в день в первые три дн и по 4 мг один раз в день в следующие два дн . В заключительные дес ть дней вводили чис- таглобулин п/к по 2 мл через день. Клиническа ремисси наступила наthe next three days - quaterone, then another five days aminocaproic acid simultaneously with triamsynolone, 4 mg twice a day for the first three days and 4 mg once a day for the next two days. In the final ten days, chloaglobuline s / c was administered in 2 ml every other day. Clinical remission stepped on
14-й день лечени . Курс лечени закончен в амбулаторных услови х.14th day of treatment. The course of treatment is completed on an outpatient basis.
Корректор И.Эрдейи ПодписноеProofreader I.Erdeyi Subscription
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU813278185A SU1202591A1 (en) | 1981-04-17 | 1981-04-17 | Method of treatment of patients ill with allergic dermatosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU813278185A SU1202591A1 (en) | 1981-04-17 | 1981-04-17 | Method of treatment of patients ill with allergic dermatosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1202591A1 true SU1202591A1 (en) | 1986-01-07 |
Family
ID=20954275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU813278185A SU1202591A1 (en) | 1981-04-17 | 1981-04-17 | Method of treatment of patients ill with allergic dermatosis |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1202591A1 (en) |
-
1981
- 1981-04-17 SU SU813278185A patent/SU1202591A1/en active
Non-Patent Citations (1)
| Title |
|---|
| Лернер И.П. и др. Методические рекомендации по диагностике, профилактике и лечению лекарственной аллергии. Киев: 1978, с. 22. Смелов Н.С. и др. Методические рекомендации по клинике, лечению и профилактике экземы. М,: 1974, с. 16. * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HG et al. | Thioridazine hydrochloride (Mellaril): Its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities. | |
| Lassus | A comparative pilot study of azapropazone and indomethacin in the treatment of psoriatic arthritis and Reiter's disease | |
| SU1202591A1 (en) | Method of treatment of patients ill with allergic dermatosis | |
| Williams et al. | Calcium Absorption in the ‘Rat in Relation to Excessive Vitamin D and Cortisone | |
| SU1105202A1 (en) | Method of treatment of gastric ulcer and duodenal ulcer | |
| SU940377A1 (en) | Method for comprehensive treatment of gastric and duodenal ulcer | |
| SU1380752A1 (en) | Method of tuberculinotherapy | |
| RU2819488C1 (en) | Method of treating psoriasis | |
| SU1097334A1 (en) | Method of treatment ischemia heart diseases | |
| SU1560221A1 (en) | Method of treating infectious-allergic rhinosinuitis | |
| RU2104000C1 (en) | Method of treatment of inflammatory processes | |
| SU923548A1 (en) | Method of treating acute ischemia of extremity | |
| SU1225574A1 (en) | Method of treatment of psoriasis | |
| Hailey et al. | Plasma concentrations of medazepam and its metabolites after oral administration | |
| SU1205916A1 (en) | Method of treatment of parodontosis | |
| SU961693A1 (en) | Chronic pielonephritis treatment method | |
| SU1215710A1 (en) | Method of treatment of tythus-paratyphoid infection and salmonollosis enterocolitis | |
| SU1114423A1 (en) | Method of treatment of neuralgia of trifacial nerve | |
| SU1097332A1 (en) | Method of treatment of infiltration and dissiminated forms of lung tuberculosis | |
| SU1437024A1 (en) | Method of treatment of acute renal insufficiency | |
| SU1611338A1 (en) | Method of treating diffuse neurodermite | |
| Siddiqui et al. | Microenema of 8-methoxypsoralen in photochemotherapy of psoriasis | |
| SU1171035A1 (en) | Method of curing syphilis | |
| SU858829A1 (en) | Method of treating virus hepatitis | |
| RU2107910C1 (en) | Method for treating cardiac ischemia disease |